Literature DB >> 32788312

SARS-CoV-2 and the pandemic of COVID-19.

Md Tanveer Adil1, Rumana Rahman2, Douglas Whitelaw3, Vigyan Jain3, Omer Al-Taan3, Farhan Rashid3, Aruna Munasinghe3, Periyathambi Jambulingam3.   

Abstract

SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30, 2020, a total of 5 899 866 positive cases were registered including 364 891 deaths. SARS-CoV-2 primarily targets the lung and enters the body through ACE2 receptors. Typical symptoms of COVID-19 include fever, cough, shortness of breath and fatigue, yet some atypical symptoms like loss of smell and taste have also been described. 20% require hospital admission due to severe disease, a third of whom need intensive support. Treatment is primarily supportive, however, prognosis is dismal in those who need invasive ventilation. Trials are ongoing to discover effective vaccines and drugs to combat the disease. Preventive strategies aim at reducing the transmission of disease by contact tracing, washing of hands, use of face masks and government-led lockdown of unnecessary activities to reduce the risk of transmission. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; Coronavirus; SARS-CoV-2; global health; viral infections

Mesh:

Year:  2020        PMID: 32788312     DOI: 10.1136/postgradmedj-2020-138386

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  42 in total

1.  Evaluation of chest CT scan finding in the patients with acute respiratory symptoms following positive results of RT-PCR-COVID19.

Authors:  Jafar Ahmadi; Firoozeh Kahkeshpour; Habib Farahmand; Ali Esmaeili Nadimi; Keyvan Ghadimi; Gholamreza Bazmandegan; Zahra Kamiab
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-02-15

2.  Lessons we learnt from Covid pandemic.

Authors:  Amrit Pokhrel
Journal:  Ann Med Surg (Lond)       Date:  2022-06-09

Review 3.  Managing children with brain tumors during the COVID-19 era: Don't stop the care!

Authors:  Michele Antonio Capozza; Silvia Triarico; Giorgio Attinà; Alberto Romano; Stefano Mastrangelo; Palma Maurizi; Paolo Frassanito; Federico Bianchi; Tommaso Verdolotti; Marco Gessi; Mario Balducci; Luca Massimi; Gianpiero Tamburrini; Antonio Ruggiero
Journal:  Comput Struct Biotechnol J       Date:  2021-01-12       Impact factor: 7.271

4.  Antiviral activity of Brazilian Green Propolis extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus 2) infection: case report and review.

Authors:  Ana C Fiorini; Carla A Scorza; Antonio-Carlos G de Almeida; Marcelo C M Fonseca; Josef Finsterer; Fernando L A Fonseca; Fulvio A Scorza
Journal:  Clinics (Sao Paulo)       Date:  2021-01-22       Impact factor: 2.365

5.  Targeting the PANoptosome with miRNA Loaded Mesenchymal Stem Cell Derived Extracellular Vesicles; a New Path to Fight Against the Covid-19?

Authors:  Zafer Çetin
Journal:  Stem Cell Rev Rep       Date:  2021-04-13       Impact factor: 5.739

6.  An unusual and atypical presentation of the novel coronavirus: A case report and brief review of the literature.

Authors:  Sultan Abdulwadoud Alshoabi; Kamel H Haider; Mahmoud A Mostafa; Abdullgabbar M Hamid; Tareef S Daqqaq
Journal:  J Taibah Univ Med Sci       Date:  2021-04-12

7.  SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.

Authors:  Nanda Kishore Routhu; Narayanaiah Cheedarla; Venkata Satish Bollimpelli; Sailaja Gangadhara; Venkata Viswanadh Edara; Lilin Lai; Anusmita Sahoo; Ayalnesh Shiferaw; Tiffany M Styles; Katharine Floyd; Stephanie Fischinger; Caroline Atyeo; Sally A Shin; Sanjeev Gumber; Shannon Kirejczyk; Kenneth H Dinnon; Pei-Yong Shi; Vineet D Menachery; Mark Tomai; Christopher B Fox; Galit Alter; Thomas H Vanderford; Lisa Gralinski; Mehul S Suthar; Rama Rao Amara
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

8.  In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor.

Authors:  Doni Dermawan; Bagas Adji Prabowo; Casilda Aulia Rakhmadina
Journal:  Inform Med Unlocked       Date:  2021-06-24

9.  Antivaccine Movement and COVID-19 Negationism: A Content Analysis of Spanish-Written Messages on Twitter.

Authors:  Ivan Herrera-Peco; Beatriz Jiménez-Gómez; Carlos Santiago Romero Magdalena; Juan José Deudero; María García-Puente; Elvira Benítez De Gracia; Carlos Ruiz Núñez
Journal:  Vaccines (Basel)       Date:  2021-06-15

Review 10.  Potential and Possible Therapeutic Effects of Melatonin on SARS-CoV-2 Infection.

Authors:  Evgeny Shchetinin; Vladimir Baturin; Eduard Arushanyan; Albert Bolatchiev; Dmitriy Bobryshev
Journal:  Antioxidants (Basel)       Date:  2022-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.